[+]
Obese vs. normal mouse (unrelated to Brestoff Parker/Reynolds experiments) (credit: Wikimedia Commons)
U.S. Patent No. 8,598,150 was awarded today (Dec. 3) for the use of an antioxidant compound called MnTBAP* for treatment of obesity and obesity-related conditions, such as insulin resistance or pre-diabetes.
The patent was filed by two Skidmore College researchers: Jonathan R. Brestoff Parker and professorThomas H. Reynolds, IV.
In unpublished mouse experiments, they found that the compound decreases obesity by promoting triglyceride breakdown and improves type 2 diabetes by modulating insulin signaling. The specific molecular target of the compound is not yet known, Brestoff Parker toldKurzweilAI in an exclusive interview./.../
No comments:
Post a Comment